MAST
LIVE

Serial Number

79209271

Owner

MAST GROUP LIMITED

Attorney

Jeffrey A. Smith

Filing Date

Nov 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MAST Trademark

Serial Number: 79209271 • Registration: 6082227

MAST is a trademark filed by MAST GROUP LIMITED on November 25, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

MAST GROUP LIMITED (5 trademarks)

Mast House, Derby Road

Entity Type: 99

Trademark Details

Filing Date

November 25, 2016

Registration Date

June 23, 2020

Published for Opposition

April 7, 2020

Goods & Services

Apparatus for recording, transmission or reproduction of sound or images; data processing equipment and computers; apparatus for measuring inoculated bacterial cultures; laboratory image analysing apparatus and instruments for detection, diagnosis and identification of treatment options of the causative agents of diseases and the capture of fluorescent, luminescent chromatic or electrical signal output upon excitation at a given wavelength from a nucleic acid amplification test which has intercalating dyes, flurophores or other tagging mechanisms; analytical apparatus for microorganism identification and the reading of antibiotic susceptibility tests, namely, recorded computer software and computer hardware used in image analysis; Recorded computer programs and software for use in molecular biology for the reading, analysis and correlation of data and reporting of microorganism identification from samples; Measuring apparatus for use in quantifying of biological materials in assay testing; laboratory research bacterial storage and cultivation apparatus; storage retrieval systems for the preservation of organisms consisting of recorded computer software for controlling insertion, removal, and storage temperature of tissue samples, lockable petri dishes, and laboratory robotic arms; Parts specially adapted for laboratory research testing equipment, namely, antibiotic and antifungal susceptibility discs, rings and tablets, paper antibiotic and antifungal susceptibility discs, rings, tablets and strips, antibiotic resistance detection discs, rings, and tablets, and paper antibiotic resistance detection discs, rings, tablets and strips; Recorded software for urine testing, antibiotic susceptibility testing, identification and detection of bacteria, veterinary pathogens and other infectious organisms and the diagnosis of urine infections and autoimmune diseases; laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, and parts therefor sold together as a unit, namely, analysers, dispensers, inoculators, interface modules and marker pins, and analysers, dispensers, inoculators, interface modules and marker pins for urine testing; Laboratory instruments for use in the preparation of samples, namely, instruments for the allocation of clinical specimen onto microtiter plates and instruments for dispensing of clinical specimens and antibiotic susceptibility discs onto microbiological culture plates; laboratory pre-poured media 96-Well plates for bacterial antibiotic susceptibility testing (AST) or identification (ID) and 90-100mm or 150mm microbiological culture plates containing Mueller Hinton agar for urine screening; laboratory glassware, namely, vials and wells for storage and preservation of bacteria; Chemical analyzers for reading laboratory sample cards for occult blood tests; Chemical analyzers for reading laboratory reaction cards including latex agglutination reaction cards; laboratory instruments, namely, chemical analyzers for reading discs, strips and circles for identification and detection of bacteria; Laboratory reaction tubes; turbidimeters; laboratory instruments, namely, amplification units for molecular biology tests for the detection of target DNA by measuring the increase in the signal output from the diagnostic assay; data processors for processing patient specimen data in medical diagnostics, reading and analysis of diagnostic test result data, and validation of analyser derived test results; recorded software operating programs for use with medical diagnostic testing and analysis equipment; apparatus for microbiological laboratory testing, namely, microscopes and microbiological safety cabinets; parts and fittings for the aforementioned goods, namely, inoculating pins, inoculating pin holders, inoculum pots, bar code readers, all-in-one PCs in drive and tablet computer formats, electronic cables, power adapters, marker assemblies, magnifiers, printers, racks for holding microtiter plates, molecular platform amplification units comprising drive modules, power modules and HMI modules and power cables, LEDs, circuit boards, bar code readers and HMIs in tablet computer form, antibiotic susceptibility testing disc dispensers, desiccant packs specially adapted for laboratory equipment, disc dispenser canisters, disc dispenser spares for repair

Pharmaceutical preparations, namely, preparations for use in antibiotic susceptibility tests for the detection and identification of infectious pathogens present in clinical and reference specimens and for use in antibiotic susceptibility tests for the detection and identification of infectious pathogens present in clinical and reference specimens; veterinary diagnostic preparations; sanitary preparations for medical use and disinfectants; nutrient media for bacteriological cultures for use in medical laboratories and near patient testing facilities for diagnostic purposes in human medicine; Nutrient media for use in medical diagnostic testing laboratories and near patient medical diagnostic testing facilities; antibiotic susceptibility tests for microbiological and infectious disease detection for medical purposes; Diagnostic reagents for medical or veterinary purposes; Kits comprising chemical, molecular, biological and microbiological reagents for medical or medical veterinary purposes; biological or chemical reagents for use in molecular biology for medical or veterinary purposes; Kits consisting of reagents for conducting enzyme-linked immune-absorbent assays (ELISA) for medical or veterinary purposes; chemical, biological, molecular and microbiological reagents for medical or veterinary purposes; Kits consisting of chemical reagents for medical use for conducting thermal amplification assays; Kits consisting of chemical reagents for medical use for thermal amplification or detection of nucleic targets; Medicated serums containing antigens for the treatment of allergies; Diagnostic antibodies for use in disease testing; antibodies for immunodiagnostic purposes; Intercalcating agents, namely, secondary antibody, conjugate, DNA-DNA, protein-protein and DNA-protein linking agents for medical or veterinary use; Medical diagnostic tests comprised of reagents and assays for detecting antibodies; proteins for medical use in binding antibodies; Medical testing kits comprising reagents for infectious disease diagnosis; Antimicrobial preparations for use in the cryopreservation of organisms; Medical diagnostic molecular reagents for use in the identification and detection of bacteria, veterinary pathogens and other infectious organisms and the diagnosis of urine infections and autoimmune diseases and none of the above being for allergy tests; Medical diagnostic reagents for urine examination reagents for the detection of occult blood in feces; reagents for immunodiagnostic tests, namely, the diagnosis of autoimmune disease; Diagnostic molecular biology kits composed primarily of reagents and assays for pathogenic detection and identification

Chemicals used in industry and science; reagents for scientific and research use and clinical and medical laboratory use; chemical reagents for scientific and research use and clinical and medical laboratory use; molecular reagents for scientific and research use and clinical and medical laboratory use; biological reagents for scientific and research use and clinical and medical laboratory use; microbiological reagents for scientific and research use and clinical and medical laboratory use; antibiotic susceptibility reagents for scientific and research use and clinical and medical laboratory use; cell growth media for the cultivation and growth of bacteria, fungi and yeast cells from clinical specimens or reference strains for use in laboratories, near patient testing laboratory facilities, and for diagnostic research purposes; Kits comprising chemical, molecular, biological and microbiological reagents for scientific, research, and clinical and medical laboratory use; Kits comprising chemical reagents for conducting enzyme-linked immunosorbent assays (ELISA) for scientific and research use and clinical and medical laboratory use; Kits comprising chemical reagents for conducting thermal amplification assays for scientific and research use, and clinical and medical laboratory use; Kits comprising chemical reagents for thermal amplification or detection of nucleic targets for scientific and research use, and clinical and medical laboratory use; assay preparations for scientific and research use and clinical laboratory use; Test kits for detecting antibodies, other than for medical or veterinary use, comprising immunofluorescence dyes, enzyme immunoassay reagents, and Western blot electrophoreses and protein gel reagents, all for use for scientific and research use, and clinical or medical laboratory use; Chemical cell culture media supplements and test kits comprised of chemical cell culture media supplements for use in laboratories, near patient testing facilities for research purposes related to identification and susceptibility testing for scientific and research use, and clinical or medical laboratory use; chemicals for use in the cryopreservation of organisms for scientific use, research use and clinical or medical laboratory use; chemical reagents for molecular biology scientific research and for use in clinical and medical laboratories; cell culture media for use in laboratories, near patient testing facilities for diagnostic research purposes, and clinical or medical laboratory use; reagents for use in scientific apparatus for antibiotic susceptibility analysis; nutrients for use in scientific apparatus for microbiological analysis; Biochemical reagents for the identification and detection of bacteria for non-medical purposes; biochemical reagents for clinical or medical laboratory use; bacterial agglutinating antisera for clinical or medical laboratory use; Laboratory chemicals, namely, stained febrile antigens; Laboratory chemicals, namely, latex for agglutination tests

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 23, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 1, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 9, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 8, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 23, 2020 FICR
NOTIFICATION PROCESSED BY IB
Aug 14, 2020 GPNX
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 18, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2020 TROA
IRREGULARITY FROM IB EXAMINED BY MPU
Nov 6, 2019 IRRH
IRREGULARITY ON REFUSAL FROM IB
Oct 23, 2019 IRRF
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 30, 2019 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 15, 2019 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 12, 2019 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 14, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 14, 2018 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 12, 2018 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 12, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 12, 2018 GNSL
SUSPENSION LETTER WRITTEN
Feb 12, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2018 CRFA
ASSIGNED TO LIE
Jan 23, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2018 REAP
REFUSAL PROCESSED BY IB
Jul 28, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 8, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 8, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 13, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 9, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 8, 2017 REPR